Black-market weight-loss injections are raising serious safety concerns after lab tests found unexpected chemicals and live bacteria in vials sold as an experimental drug.
Story Snapshot
- CBS News bought two vials sold as retatrutide and sent them to labs
- Tests found phenylacetic acid and bacterial colonies in samples
- Labels said “research use only,” yet sales targeted consumers
- Food and Drug Administration says these are unapproved drugs
What CBS Bought And What Labs Found
CBS News purchased two vials marketed online as retatrutide, an experimental weight-loss drug under study by Eli Lilly, and had independent scientists analyze them. Chemist Paul Galpin reported both samples matched a basic reference standard he made for retatrutide, but not the exact clinical-trial drug. He also identified phenylacetic acid, which he described as a filler and not part of a verified medicine. A second lab found 13 colonies of bacteria in one sample, flagging an infection risk if injected.
The bottles carried a warning that said “research use only, not for human consumption,” while being sold in consumer-facing ways, including with the look and pitch of a product someone might inject. The Food and Drug Administration warns that sellers use such labels while still marketing to consumers for human use, sometimes even adding dosing advice. That gulf between the label and the sales pitch is where people get hurt and where common sense should kick in.
Black Market Products Are Not Trial-Grade Medicine
Eli Lilly, the company developing retatrutide, drew a clear line between its trial drug and black market vials. Chief Medical Officer David A. Hyman said the company is running controlled studies and called the online products “entirely unverified, unapproved.” Lilly also said no retatrutide medicine has been approved for use. That matches the basic rule of medicine in America: if the Food and Drug Administration has not approved it, you should not buy it from a website and put it in your body.
Regulators backed that up with action. Food and Drug Administration warning letters told sellers that their retatrutide offerings were unapproved new drugs being sold in violation of federal law, including the Food, Drug, and Cosmetic Act sections on approval and interstate sales. When government says a product is an unapproved drug, that is not a paperwork glitch. It means no one has proven safety, dose, purity, or quality to the standards the law demands.
Why The Findings Matter For Everyday Buyers
Demand for weight loss drugs has exploded. When demand surges, and real supply is tight or costly, shadow markets fill the gap. That is how shoppers end up with vials that may have the wrong ingredient, harmful extras, too much or too little active drug, or none at all, as the Food and Drug Administration has warned for this class of products. The CBS tests fit that pattern: a fragrance chemical and bacteria do not belong in anything you inject in the hope of losing weight.
Some sellers try to dodge oversight by saying “for research use,” then turn around and sell to anyone with a credit card. The Food and Drug Administration has called out that tactic directly, because it misleads people into thinking the sale is legal or the product is safe enough to try. That runs against basic conservative values of truth in advertising, personal responsibility, and the rule of law. If the label says not for humans, it should not reach your refrigerator or your skin.
What A Smart Consumer Does Next
Check the approval status before you buy or inject. If the Food and Drug Administration has not approved it, skip it. If a company says it is in clinical trials, that means it is not for sale to consumers. If the bottle says research use only, believe it. If a website offers medical dosing but will not ask for a prescription from your own doctor, close the tab. These are bright-line signals that protect your health and your wallet.
🇺🇸 A "miracle" weight loss shot from a Brooklyn bodega turned out to be fragrance filler and BACTERIA
CBS News bought retatrutide, an experimental drug Eli Lilly is still testing, from a clinic website, a gym and a corner store without ever talking to a doctor.
Lab tests showed… pic.twitter.com/dYvqFbMj25
— Mario Nawfal (@MarioNawfal) October 22, 2026
The CBS report covered two samples, which do not prove what is in every vial sold online, but the legal and safety warnings from regulators and the drug maker apply across the board. Here is the bottom line: weight loss is a long game, and shortcuts can cut deep. Trust products that prove themselves. Avoid sellers that hide behind a “research” label while reaching for your arm. Your health is worth more than a mystery vial.
Sources:
cbsnews.com, fda.gov, investor.lilly.com
